Daniel L. Cheney - Concepedia

Author

Daniel L. Cheney

Bristol-Myers Squibb (United States)ORCID

Also Known As

Cheney, Daniel, D L Cheney, D. Cheney, D. L. CHENEY, D. L. Cheney, D.L. Cheney, Daniel Cheney, Daniel L Cheney, Daniel L. CHENEY, Daniel L. Cheney

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Georgia Institute of Technology Bristol-Myers Squibb (Germany)Bristol-Myers Squibb (Sweden)Biocon (India)

About

Daniel L. Cheney is an author at Bristol-Myers Squibb (United States) specializing in natural sciences, medicine, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Natural Sciences	22	30	1.5K
2	Medicine	21	30	1.3K
3	Biochemistry	21	27	1.3K
4	Engineering	8	8	430
5	Applied Physics	1	1	39

Daniel L. Cheney

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
New 4-Point Pharmacophore Method for Molecular Similarity and Diversity Applications: Overview of the Method and Applications, Including a Novel Approach to the Design of Combinatorial Libraries Containing Privileged Substructures Jonathan Mason, Isabelle Morize, Paul R. Menard, Journal of Medicinal Chemistry Drug TargetNovel ApproachMolecular BiologyChemical BiologyMedicinal Chemistry	1999	376
Macrocycle Conformational Sampling with MacroModel K. Shawn Watts, Pranav Dalal, Andrew J. Tebben, Journal of Chemical Information and Modeling EngineeringComputational ChemistryMarkov Chain Monte CarloChemistryMolecular Design	2014	186
Improving Accuracy, Diversity, and Speed with Prime Macrocycle Conformational Sampling Dan Sindhikara, Steven A. Spronk, Tyler Day, Journal of Chemical Information and Modeling Crystal StructureStructural BioinformaticsBiomolecular Structure PredictionMolecular BiologyComputational Chemistry	2017	110
AP-Net: An atomic-pairwise neural network for smooth and transferable interaction potentials Zachary L. Glick, Derek P. Metcalf, Alexios Koutsoukas, The Journal of Chemical Physics	2020	71
In vitro characterization of benzodiazepine receptor agonists, antagonists, inverse agonists and agonist/antagonists. Paul L. Wood, Patricia Loo, Albert Braunwalder, Journal of Pharmacology and Experimental Therapeutics	1984	69
Achieving structural diversity using the perpendicular conformation of alpha-substituted phenylcyclopropanes to mimic the bioactive conformation of ortho-substituted biphenyl P4 moieties: Discovery of novel, highly potent inhibitors of Factor Xa Jennifer X. Qiao, Daniel L. Cheney, Richard Alexander, Bioorganic & Medicinal Chemistry Letters Bioactive ConformationMedicinal ChemistryHeterocyclicBiochemistryNatural Sciences	2008	55
Optimization of the β-Aminoester class of factor Xa inhibitors. part 2: Identification of FXV673 as a potent and selective inhibitor with excellent In vivo anticoagulant activity Kevin R. Guertin, Charles J. Gardner, Scott I. Klein, Bioorganic & Medicinal Chemistry Letters ThrombosisMedicinal ChemistryBiochemistryβ-Aminoester ClassPart 2	2002	52
Atropisomer Control in Macrocyclic Factor VIIa Inhibitors Peter W. Glunz, Luciano Mueller, Daniel L. Cheney, Journal of Medicinal Chemistry Combinatorial ChemistryBioorganic ChemistryMolecular BiologyPharmacotherapyChemical Biology	2016	52
Discovery and Development of 5-[(5<i>S</i>,9<i>R</i>)-9- (4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1- methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]non- 7-yl-methyl]-3-thiophenecarboxylic Acid (BMS-587101)A Small Molecule Antagonist of Leukocyte Function Associated Antigen-1 Dominique Potin, Michèle Launay, Francoise Monatlik, Journal of Medicinal Chemistry	2006	51
Analysis and optimization of structure-based virtual screening protocols Andrew C. Good, Daniel L. Cheney, Doree Sitkoff, Journal of Molecular Graphics and Modelling Virtual ScreeningEngineeringInformation SecuritySoftware TestingSecurity Testing	2003	44

Page 1